Skip to content

Cencora COR Other Healthcare Solutions — Revenue

Other product segments

Alliance Healthcare
$6.52B+12.9%
Animal Health
$1.44B+5.3%
Other non-strategic businesses
$619.78M+4.5%

Similar metrics at other companies

3D Systems logo
DDDHealthcare Solutions — Total Revenue
$50.13M+21.3%
Cross Country Healthcare logo
CCRNOther Services — Revenue from services
$7.35M-14.1%
GoodRx Holdings, Inc. logo
GDRXOther revenue — Revenue
$3.69M-15.8%
Voya Financial logo
VOYAHealth Solutions — Revenue
$11M+69.2%
TruBridge, Inc. logo
TBRGConsulting and other services — Total revenues
$953K+9.5%
TruBridge, Inc. logo
TBRGProfessional services and other — Total revenues
$948K+153%

Other financials

Income statement

See full
Revenue$78.4B+3.8%
Gross profit$3.6B+17.3%
Operating income$1.1B+10.3%
Net income$1.6B+129%
EPS (diluted)$8.40+128%

Balance sheet

See full
Cash & equivalents$2.2B+10.0%
Total debt$12.2B+71.9%
Total equity$3.4B+235%
Total assets$81.7B+14.7%

Cash flow

See full
Operating cash flow-$2.3B+15.2%
CapEx$165.6M+28.3%
Free cash flow-$2.4B+14.2%

Valuation

See full
Market cap$55.83B-1.9%
Enterprise value$65.84B+6.1%
P/E15.5×+3.1×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.4pp
Operating margin0.8%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Return on equity130.6%-99.8pp
Debt / equity3.6×-3.4×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by Cencora in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Cencora’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cencora's other healthcare solutions — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cencora's other healthcare solutions — revenue?
Cencora (COR) reported other healthcare solutions — revenue of $1.05B in Q1 2026.
What does other healthcare solutions — revenue mean?
This metric represents the total revenue generated from specialized healthcare services, consulting, and logistics solutions that fall outside of traditional pharmaceutical wholesale distribution. It captures the financial performance of value-added services provided to pharmaceutical manufacturers, healthcare providers, and other industry stakeholders. This segment reflects the company's diversification into high-margin service-based revenue streams beyond core drug supply chain activities.